These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

701 related items for PubMed ID: 17505260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ, Hutchins G, Love C, Wenck S, Daggy J.
    Cancer; 2005 Aug 01; 104(3):570-9. PubMed ID: 15977211
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB, Soo V, Kraas J, Shen P, Levine EA.
    Arch Surg; 2006 Mar 01; 141(3):284-8. PubMed ID: 16549694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
    Klode J, Dissemond J, Grabbe S, Hillen U, Poeppel T, Boeing C.
    Dermatol Surg; 2010 Apr 01; 36(4):439-45. PubMed ID: 20187901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
    Macfarlane DJ, Sondak V, Johnson T, Wahl RL.
    J Clin Oncol; 1998 May 01; 16(5):1770-6. PubMed ID: 9586890
    [Abstract] [Full Text] [Related]

  • 11. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
    Horn J, Lock-Andersen J, Sjøstrand H, Loft A.
    Eur J Nucl Med Mol Imaging; 2006 Aug 01; 33(8):887-92. PubMed ID: 16586078
    [Abstract] [Full Text] [Related]

  • 12. Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy.
    Libberecht K, Husada G, Peeters T, Michiels P, Gys T, Molderez C.
    Acta Chir Belg; 2005 Aug 01; 105(6):621-5. PubMed ID: 16438072
    [Abstract] [Full Text] [Related]

  • 13. Baseline staging in cutaneous malignant melanoma.
    Hafner J, Schmid MH, Kempf W, Burg G, Künzi W, Meuli-Simmen C, Neff P, Meyer V, Mihic D, Garzoli E, Jungius KP, Seifert B, Dummer R, Steinert H.
    Br J Dermatol; 2004 Apr 01; 150(4):677-86. PubMed ID: 15099363
    [Abstract] [Full Text] [Related]

  • 14. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ, Meyers MO, Frank J, Amos KD, Stitzenberg KB, Ollila DW.
    Am J Surg; 2014 Apr 01; 207(4):549-54. PubMed ID: 24674829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.